|
ACVR1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.72004641033163E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.99680288865056E-15 |
| Normal-vs-Stage2 |
3.15970000164256E-08 |
| Normal-vs-Stage3 |
3.2267000182884E-09 |
| Normal-vs-Stage4 |
5.658300E-03 |
| Stage1-vs-Stage2 |
7.563400E-01 |
| Stage1-vs-Stage3 |
2.289200E-01 |
| Stage1-vs-Stage4 |
4.393800E-01 |
| Stage2-vs-Stage3 |
5.929000E-01 |
| Stage2-vs-Stage4 |
5.922000E-01 |
| Stage3-vs-Stage4 |
8.241000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.16573417585641E-14 |
| Normal-vs-AfricanAmerican |
2.57629473310317E-11 |
| Normal-vs-Asian |
5.63319999999923E-05 |
| Caucasian-vs-AfricanAmerican |
5.999800E-01 |
| Caucasian-vs-Asian |
8.291400E-01 |
| AfricanAmerican-vs-Asian |
6.678000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62525548574877E-12 |
| Normal-vs-Female |
1.74389999996194E-07 |
| Male-vs-Female |
1.618870E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.94990004540341E-09 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
2.80189982326817E-10 |
| Normal-vs-Extreme_Obese |
2.70490000398027E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.069390E-01 |
| Normal_Weight-vs-Obese |
4.575200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.370800E-01 |
| Extreme_Weight-vs-Obese |
5.904400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.996800E-01 |
| Obese-vs-Extreme_Obese |
1.655990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.171900E-04 |
| Normal-vs-Age(41-60Yrs) |
5.74189584767737E-11 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
3.27250004872326E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.466400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.921200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.617600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.156500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.705550E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.370600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.03170813506404E-14 |
| Normal-VS-Type2 PRCC |
1.7421619702418E-12 |
| Normal-VS-KIRP CIMP |
1.698330E-02 |
| Normal-VS-Unclassified PRCC |
6.95460000033066E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.524200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.700300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.110800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.088000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.832170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.546960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11053396981242E-13 |
| Normal-vs-N1 |
8.48240000017597E-07 |
| Normal-vs-N2 |
2.006600E-01 |
| N0-vs-N1 |
2.932100E-02 |
| N0-vs-N2 |
1.980140E-02 |
| N1-vs-N2 |
1.930190E-01 |
|
|
